Ann: Significant Immunological Outcomes in BIT225 HIV-1 Trial, page-46

Not just HIV. Bit225 will be a compound useful in treating many viruses due to its ability to work in previously inaccessible areas of the body. It is great news and I actually nearly fell off my chair when I looked at the screen after lunch! In my opinion, this will be heading higher after the day traders have finished playing. I have been a long-term holder and a recent doubter due to deadline misses but the result is impressive indeed. The new assay was really worth the wait! Congrats to the long term holders.